Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in mice-Reference-Cited by-同舟云学术

Cardiomyocyte expression of PPARγ leads to cardiac dysfunction in mice

Published:2007-10-01 Issue:10 Volume:117 Page:2791-2801
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Son Ni-Huiping,Park Tae-Sik,Yamashita Haruyo,Yokoyama Masayoshi,Huggins Lesley A.,Okajima Kazue,Homma Shunichi,Szabolcs Matthias J.,Huang Li-Shin,Goldberg Ira J.

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference53 articles.

1. Minireview: Lipid Metabolism, Metabolic Diseases, and Peroxisome Proliferator-Activated Receptors

2. Therapeutic Roles of Peroxisome Proliferator–Activated Receptor Agonists

3. PPAR Signaling in the Control of Cardiac Energy Metabolism

4. Cardiomyocyte-Specific Knockout and Agonist of Peroxisome Proliferator–Activated Receptor-γ Both Induce Cardiac Hypertrophy in Mice

5. Adipocyte-specific Gene Expression and Adipogenic Steatosis in the Mouse Liver Due to Peroxisome Proliferator-activated Receptor γ1 (PPARγ1) Overexpression

Cited by 300 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PPARγ drives mitochondrial stress signaling and the loss of atrial cardiomyocytes in newborn mice exposed to hyperoxia;Redox Biology;2024-10

2. The beneficial impact of curcumin on cardiac lipotoxicity;Journal of Pharmacy and Pharmacology;2024-08-24

3. Mitochondrial abnormalities in septic cardiomyopathy;Minerva Anestesiologica;2024-07

4. Pioglitazone Alleviates β1-Adrenergic Receptor Antibody-Induced Atrial Fibrillation Susceptivity via Mitigation of PPAR-γ-Mediated Metabolic Inflexibility;Current Medicinal Chemistry;2024-05-30

5. Qiliqiangxin: A multifaceted holistic treatment for heart failure or a pharmacological probe for the identification of cardioprotective mechanisms?;European Journal of Heart Failure;2023-11-14